Market Introduction
Neurovascular devices are used to treat neurovascular diseases that possibly affect the network of blood vessels that surround the brain. Neurovascular disorders lead to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis, and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems.
Market Overview and Dynamics
The South and Central America neurovascular devices market is expected to reach US$ 224.08 Mn in 2027 from US$ 181.40 Mn in 2019. The market is estimated to grow with a CAGR of 2.8% from 2020-2027. Key factors that are driving growth of South and Central America Neurovascular Devices market are Increasing Incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, the market is expected to grow at slower pace owing to the factors such as high cost of embolization coils and lack of expert professionals operating neurovascular disorders.
Key Market Segments
The South and Central America neurovascular devices market, based on the product was segmented into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems and support devices. The aneurysm coiling & embolization devices held the largest share of the market in 2019, and is anticipated to register the highest CAGR in the market during the forecast period.
The South and Central America neurovascular devices market, based on the application was segmented into cerebral aneurysms, ischemic strokes, arteriovenous malformation & fistulas, and other applications. In 2019, ischemic strokes segment held the largest share of the market and is expected to register the highest CAGR in the market during the forecast period.
Based on end user, the South and Central America neurovascular devices market, was segmented into hospitals, ambulatory surgical centers and specialized clinics. In 2019, hospitals segment held the largest share of the market and is registered to dominate the market at the highest CAGR during the forecast period.
Major Sources and Companies Listed
Some of the major primary and secondary sources for South and Central America neurovascular devices market included in the report are Brazilian Institute of Neuroscience and Neurotechnology (BRAINN); São Paulo Research Foundation (FAPESP); World Bank; World Stroke Organisation (WSO); and World Health Organisation (WHO); among others.
Reasons to buy the report
South and Central America North America Neurovascular Devices market –
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 181.40 Million |
| Market Size by 2027 | US$ 224.08 Million |
| CAGR (2020 - 2027) | 2.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South and Central America Neurovascular Devices Market is valued at US$ 181.40 Million in 2019, it is projected to reach US$ 224.08 Million by 2027.
As per our report South and Central America Neurovascular Devices Market, the market size is valued at US$ 181.40 Million in 2019, projecting it to reach US$ 224.08 Million by 2027. This translates to a CAGR of approximately 2.8% during the forecast period.
The South and Central America Neurovascular Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Neurovascular Devices Market report:
The South and Central America Neurovascular Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Neurovascular Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Neurovascular Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)